Home › Companies › Mesa Laboratories, Inc. › 2025-2026

Mesa Laboratories, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Mesa Laboratories, Inc.’s Form 8-K, filed 2025-08-25 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 11Reported items
  • 235Asset managers
  • 2,319Fund votes
  • 2025-08-22Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Mesa Laboratories, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Mesa Laboratories, Inc.

These tallies are Mesa Laboratories, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-08-25 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Mesa Laboratories, Inc. — official shareholder meeting results, meeting held 2025-08-22
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: John J. Sullivan, Ph.D. 4,690,793---- 195,707316,877 Majority: yes
Elect Director: Gary M. Owens 4,717,660---- 168,840316,877 Majority: yes
Elect Director: Jennifer S. Alltoft 4,775,822---- 110,678316,877 Majority: yes
Elect Director: Shannon M. Hall 4,767,236---- 119,264316,877 Majority: yes
Elect Director: Shiraz S. Ladiwala 4,788,493---- 98,007316,877 Majority: yes
Elect Director: R. Tony Tripeny 4,844,064---- 42,436316,877 Majority: yes
Elect Director: Mark C. Capone 4,845,315---- 41,185316,877 Majority: yes
Proposal 2: Ratification of the selection by our Audit Committee of Baker Tilly US, LLP to serve as the Company ' s independent registered public accounting firm for the fiscal year ending March 31, 2026 The appointment of Baker Tilly US, LLP as the Company's 5,200,7891,732856 ---- Majority: yes
Proposal 3: Approval on a non-binding basis of the compensation of the Company's named executive officers The compensation of the Company's named executive officers, as disclosed in the proxy statement, was approved on a non-binding advisory basis: 4,476,544275,297134,659 --316,877 Majority: yes
Proposal 4: Approval of an amendment to the Mesa Laboratories, Inc 4,601,685247,47637,339 --316,877 Majority: yes

Source: Mesa Laboratories, Inc., Form 8-K, filed with the SEC on 2025-08-25 — read the filing on EDGAR.

How asset managers voted at the Mesa Laboratories, Inc. 2025-2026 meeting

Each item below shows how the 235 asset managers that disclosed a Mesa Laboratories, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Mesa Laboratories, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on an advisory basis, the Company's named executive officer compensation.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 4,476,544AGAINST: 275,297

Mesa Laboratories, Inc.’s own tally for this item (“Proposal 3: Approval on a non-binding basis of the compensation of the Company's named executive officers The compensation of the Company's named executive officers, as disclosed in the proxy statement, was approved on a”): 4,476,544 for, 275,297 against, per its Form 8-K filed 2025-08-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 5,409,155 outstanding shares: 83% for, 5% against (88% of the company cast a for/against vote).

The 231 asset managers below cast 97% of the shares they voted on this item FOR (4,626,168 for, 150,389 against).

FOR 95%
FOR: 4,626,168 (94.8%)AGAINST: 150,389 (3.1%)ABSTAIN: 102,198 (2.1%)NOT VOTED: 223 (0.0%)
Largest asset managers voting on “To approve, on an advisory basis, the Company's named executive officer compensation.” at Mesa Laboratories, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock732,9841,043 00For
CONESTOGA FUNDS404,5100 00For
Vanguard379,724318 00For
Royce247,6060 00For
Janus Henderson222,0060 00For
Ranger Investment Management, L.P.187,3570 00For
State Street181,44949 00For
GENEVA CAPITAL MANAGEMENT LLC170,1310 00For
Conestoga Capital Advisors, LLC137,2270 00For
GEODE CAPITAL MANAGEMENT, LLC128,6780 00For
Fidelity124,1250 00For
EAGLE ASSET MANAGEMENT INC118,7090 00For
Charles Schwab118,4760 00For
ATLANTA CAPITAL MANAGEMENT CO L L C115,2160 00For
JANUS INVESTMENT FUND105,4800 00For
Russell Investments102,5200 00For
Select Equity Group, L.P.00 102,1980Abstain
Nationwide75,4800 00For
Columbia Threadneedle72,5790 00For
Northern Trust71,4810 00For
KENNEDY CAPITAL MANAGEMENT LLC71,3140 00For
Dimensional63,7500 00For
RAYMOND JAMES & ASSOCIATES60,2790 00For
Bridge Builder Trust59,9980 00For
CRAWFORD INVESTMENT COUNSEL INC51,9640 00For

Showing the 25 largest of 231 asset managers. See all 231 in the interactive database.

2. Election of directors: J. Sullivan

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 4,690,793WITHHELD: 195,707

Mesa Laboratories, Inc.’s own tally for this item (“Elect Director: John J. Sullivan, Ph.D.”): 4,690,793 for, 195,707 withheld, per its Form 8-K filed 2025-08-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 5,409,155 outstanding shares: 87% for, 4% withheld (90% of the company cast a for/withheld vote).

The 63 asset managers below cast 100% of the shares they voted on this item FOR (2,488,628 for, 0 against).

FOR 99.9%
FOR: 2,488,628 (100.0%)ABSTAIN: 626 (0.0%)
Largest asset managers voting on “Election of directors: J. Sullivan” at Mesa Laboratories, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock563,6160 00For
CONESTOGA FUNDS404,5100 00For
Vanguard365,3170 3180For
Royce246,4150 00For
Fidelity121,3110 00For
JANUS INVESTMENT FUND105,4800 00For
State Street82,7780 30For
Nationwide75,4800 00For
Columbia Threadneedle72,5790 00For
Bridge Builder Trust59,9980 00For
Charles Schwab56,7270 00For
Dimensional49,2180 00For
UNIFIED SERIES TRUST38,3640 00For
Russell Investments33,4750 00For
WisdomTree17,8540 00For
Goldman Sachs17,1480 00For
DIAMOND HILL FUNDS14,8250 00For
American Century13,3950 00For
Transamerica11,2990 00For
Equitable11,1390 00For
Jackson National11,0620 00For
TIAA9,9580 00For
QUANTITATIVE MASTER SERIES LLC8,8980 00For
Invesco8,1860 00For
Lincoln Financial7,8440 00For

Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.

3. Election of directors: G. Owens

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 4,717,660WITHHELD: 168,840

Mesa Laboratories, Inc.’s own tally for this item (“Elect Director: Gary M. Owens”): 4,717,660 for, 168,840 withheld, per its Form 8-K filed 2025-08-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 5,409,155 outstanding shares: 87% for, 3% withheld (90% of the company cast a for/withheld vote).

The 63 asset managers below cast 100% of the shares they voted on this item FOR (2,488,523 for, 0 against).

FOR 99.9%
FOR: 2,488,523 (100.0%)ABSTAIN: 731 (0.0%)
Largest asset managers voting on “Election of directors: G. Owens” at Mesa Laboratories, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock563,6160 00For
CONESTOGA FUNDS404,5100 00For
Vanguard365,0060 6290For
Royce246,4150 00For
Fidelity121,3110 00For
JANUS INVESTMENT FUND105,4800 00For
State Street82,6790 1020For
Nationwide75,4800 00For
Columbia Threadneedle72,5790 00For
Bridge Builder Trust59,9980 00For
Charles Schwab56,7270 00For
Dimensional49,2180 00For
UNIFIED SERIES TRUST38,3640 00For
Russell Investments33,4750 00For
WisdomTree17,8540 00For
Goldman Sachs17,1480 00For
DIAMOND HILL FUNDS14,8250 00For
American Century13,3950 00For
Transamerica11,2990 00For
Equitable11,1390 00For
Jackson National11,0620 00For
TIAA9,9580 00For
QUANTITATIVE MASTER SERIES LLC8,8980 00For
Invesco8,1860 00For
Lincoln Financial7,8440 00For

Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.

4. Election of directors: J. Alltoft

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 4,775,822WITHHELD: 110,678

Mesa Laboratories, Inc.’s own tally for this item (“Elect Director: Jennifer S. Alltoft”): 4,775,822 for, 110,678 withheld, per its Form 8-K filed 2025-08-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 5,409,155 outstanding shares: 88% for, 2% withheld (90% of the company cast a for/withheld vote).

The 63 asset managers below cast 100% of the shares they voted on this item FOR (2,481,327 for, 0 against).

FOR 99.6%
FOR: 2,481,327 (99.7%)ABSTAIN: 7,926 (0.3%)
Largest asset managers voting on “Election of directors: J. Alltoft” at Mesa Laboratories, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock563,6160 00For
CONESTOGA FUNDS404,5100 00For
Vanguard364,6880 9460For
Royce246,4150 00For
Fidelity121,3110 00For
JANUS INVESTMENT FUND105,4800 00For
State Street82,6790 1020For
Nationwide75,4800 00For
Columbia Threadneedle72,5790 00For
Bridge Builder Trust54,2340 5,7640For
Charles Schwab56,7270 00For
Dimensional49,2180 00For
UNIFIED SERIES TRUST38,3640 00For
Russell Investments33,4750 00For
WisdomTree17,8540 00For
Goldman Sachs17,1480 00For
DIAMOND HILL FUNDS14,8250 00For
American Century13,3950 00For
Transamerica11,2990 00For
Equitable11,1390 00For
Jackson National11,0620 00For
TIAA9,9580 00For
QUANTITATIVE MASTER SERIES LLC8,8980 00For
Invesco8,1860 00For
Lincoln Financial7,8440 00For

Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.

5. Election of directors: M. Capone

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%
FOR: 4,845,315WITHHELD: 41,185

Mesa Laboratories, Inc.’s own tally for this item (“Elect Director: Mark C. Capone”): 4,845,315 for, 41,185 withheld, per its Form 8-K filed 2025-08-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 5,409,155 outstanding shares: 90% for, 0.8% withheld (90% of the company cast a for/withheld vote).

The 63 asset managers below cast 100% of the shares they voted on this item FOR (2,489,254 for, 0 against).

FOR 100%
FOR: 2,489,254 (100.0%)
Largest asset managers voting on “Election of directors: M. Capone” at Mesa Laboratories, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock563,6160 00For
CONESTOGA FUNDS404,5100 00For
Vanguard365,6350 00For
Royce246,4150 00For
Fidelity121,3110 00For
JANUS INVESTMENT FUND105,4800 00For
State Street82,7810 00For
Nationwide75,4800 00For
Columbia Threadneedle72,5790 00For
Bridge Builder Trust59,9980 00For
Charles Schwab56,7270 00For
Dimensional49,2180 00For
UNIFIED SERIES TRUST38,3640 00For
Russell Investments33,4750 00For
WisdomTree17,8540 00For
Goldman Sachs17,1480 00For
DIAMOND HILL FUNDS14,8250 00For
American Century13,3950 00For
Transamerica11,2990 00For
Equitable11,1390 00For
Jackson National11,0620 00For
TIAA9,9580 00For
QUANTITATIVE MASTER SERIES LLC8,8980 00For
Invesco8,1860 00For
Lincoln Financial7,8440 00For

Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.

6. Election of directors: T. Tripeny

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%
FOR: 4,844,064WITHHELD: 42,436

Mesa Laboratories, Inc.’s own tally for this item (“Elect Director: R. Tony Tripeny”): 4,844,064 for, 42,436 withheld, per its Form 8-K filed 2025-08-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 5,409,155 outstanding shares: 90% for, 0.8% withheld (90% of the company cast a for/withheld vote).

The 63 asset managers below cast 100% of the shares they voted on this item FOR (2,489,254 for, 0 against).

FOR 100%
FOR: 2,489,254 (100.0%)
Largest asset managers voting on “Election of directors: T. Tripeny” at Mesa Laboratories, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock563,6160 00For
CONESTOGA FUNDS404,5100 00For
Vanguard365,6350 00For
Royce246,4150 00For
Fidelity121,3110 00For
JANUS INVESTMENT FUND105,4800 00For
State Street82,7810 00For
Nationwide75,4800 00For
Columbia Threadneedle72,5790 00For
Bridge Builder Trust59,9980 00For
Charles Schwab56,7270 00For
Dimensional49,2180 00For
UNIFIED SERIES TRUST38,3640 00For
Russell Investments33,4750 00For
WisdomTree17,8540 00For
Goldman Sachs17,1480 00For
DIAMOND HILL FUNDS14,8250 00For
American Century13,3950 00For
Transamerica11,2990 00For
Equitable11,1390 00For
Jackson National11,0620 00For
TIAA9,9580 00For
QUANTITATIVE MASTER SERIES LLC8,8980 00For
Invesco8,1860 00For
Lincoln Financial7,8440 00For

Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.

7. Election of directors: S. Hall

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 4,767,236WITHHELD: 119,264

Mesa Laboratories, Inc.’s own tally for this item (“Elect Director: Shannon M. Hall”): 4,767,236 for, 119,264 withheld, per its Form 8-K filed 2025-08-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 5,409,155 outstanding shares: 88% for, 2% withheld (90% of the company cast a for/withheld vote).

The 63 asset managers below cast 100% of the shares they voted on this item FOR (2,481,327 for, 0 against).

FOR 99.6%
FOR: 2,481,327 (99.7%)ABSTAIN: 7,926 (0.3%)
Largest asset managers voting on “Election of directors: S. Hall” at Mesa Laboratories, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock563,6160 00For
CONESTOGA FUNDS404,5100 00For
Vanguard364,6880 9460For
Royce246,4150 00For
Fidelity121,3110 00For
JANUS INVESTMENT FUND105,4800 00For
State Street82,6790 1020For
Nationwide75,4800 00For
Columbia Threadneedle72,5790 00For
Bridge Builder Trust54,2340 5,7640For
Charles Schwab56,7270 00For
Dimensional49,2180 00For
UNIFIED SERIES TRUST38,3640 00For
Russell Investments33,4750 00For
WisdomTree17,8540 00For
Goldman Sachs17,1480 00For
DIAMOND HILL FUNDS14,8250 00For
American Century13,3950 00For
Transamerica11,2990 00For
Equitable11,1390 00For
Jackson National11,0620 00For
TIAA9,9580 00For
QUANTITATIVE MASTER SERIES LLC8,8980 00For
Invesco8,1860 00For
Lincoln Financial7,8440 00For

Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.

8. Election of directors: S. Ladiwala

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 4,788,493WITHHELD: 98,007

Mesa Laboratories, Inc.’s own tally for this item (“Elect Director: Shiraz S. Ladiwala”): 4,788,493 for, 98,007 withheld, per its Form 8-K filed 2025-08-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 5,409,155 outstanding shares: 89% for, 2% withheld (90% of the company cast a for/withheld vote).

The 63 asset managers below cast 100% of the shares they voted on this item FOR (2,481,327 for, 0 against).

FOR 99.6%
FOR: 2,481,327 (99.7%)ABSTAIN: 7,926 (0.3%)
Largest asset managers voting on “Election of directors: S. Ladiwala” at Mesa Laboratories, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock563,6160 00For
CONESTOGA FUNDS404,5100 00For
Vanguard364,6880 9460For
Royce246,4150 00For
Fidelity121,3110 00For
JANUS INVESTMENT FUND105,4800 00For
State Street82,6790 1020For
Nationwide75,4800 00For
Columbia Threadneedle72,5790 00For
Bridge Builder Trust54,2340 5,7640For
Charles Schwab56,7270 00For
Dimensional49,2180 00For
UNIFIED SERIES TRUST38,3640 00For
Russell Investments33,4750 00For
WisdomTree17,8540 00For
Goldman Sachs17,1480 00For
DIAMOND HILL FUNDS14,8250 00For
American Century13,3950 00For
Transamerica11,2990 00For
Equitable11,1390 00For
Jackson National11,0620 00For
TIAA9,9580 00For
QUANTITATIVE MASTER SERIES LLC8,8980 00For
Invesco8,1860 00For
Lincoln Financial7,8440 00For

Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.

9. To ratify the appointment of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the year ending March 31, 2026.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 5,200,789AGAINST: 1,732

Mesa Laboratories, Inc.’s own tally for this item (“Proposal 2: Ratification of the selection by our Audit Committee of Baker Tilly US, LLP to serve as the Company ' s independent registered public accounting firm for the fiscal year ending March 31, 2026 The appointment ”): 5,200,789 for, 1,732 against, per its Form 8-K filed 2025-08-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 5,409,155 outstanding shares: 96% for, 0.1% against (96% of the company cast a for/against vote).

The 63 asset managers below cast 100% of the shares they voted on this item FOR (2,489,254 for, 0 against).

FOR 100%
FOR: 2,489,254 (100.0%)
Largest asset managers voting on “To ratify the appointment of Baker Tilly US, LLP as the Company's independent registered public accounting fir” at Mesa Laboratories, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock563,6160 00For
CONESTOGA FUNDS404,5100 00For
Vanguard365,6350 00For
Royce246,4150 00For
Fidelity121,3110 00For
JANUS INVESTMENT FUND105,4800 00For
State Street82,7810 00For
Nationwide75,4800 00For
Columbia Threadneedle72,5790 00For
Bridge Builder Trust59,9980 00For
Charles Schwab56,7270 00For
Dimensional49,2180 00For
UNIFIED SERIES TRUST38,3640 00For
Russell Investments33,4750 00For
WisdomTree17,8540 00For
Goldman Sachs17,1480 00For
DIAMOND HILL FUNDS14,8250 00For
American Century13,3950 00For
Transamerica11,2990 00For
Equitable11,1390 00For
Jackson National11,0620 00For
TIAA9,9580 00For
QUANTITATIVE MASTER SERIES LLC8,8980 00For
Invesco8,1860 00For
Lincoln Financial7,8440 00For

Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.

10. To approve the Amendment to the Mesa Laboratories, Inc. 2021 Equity Incentive Plan.

COMPENSATIONMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 4,601,685AGAINST: 247,476

Mesa Laboratories, Inc.’s own tally for this item (“Proposal 4: Approval of an amendment to the Mesa Laboratories, Inc”): 4,601,685 for, 247,476 against, per its Form 8-K filed 2025-08-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 5,409,155 outstanding shares: 85% for, 5% against (90% of the company cast a for/against vote).

The 62 asset managers below cast 99.1% of the shares they voted on this item FOR (2,462,732 for, 20,403 against).

FOR 99.1%
FOR: 2,462,732 (99.1%)AGAINST: 20,403 (0.8%)ABSTAIN: 1,400 (0.1%)
Largest asset managers voting on “To approve the Amendment to the Mesa Laboratories, Inc. 2021 Equity Incentive Plan.” at Mesa Laboratories, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock563,6160 00For
CONESTOGA FUNDS404,5100 00For
Vanguard365,006629 00For
Royce246,4150 00For
Fidelity121,3110 00For
JANUS INVESTMENT FUND105,4800 00For
State Street82,674107 00For
Nationwide75,4800 00For
Columbia Threadneedle72,5790 00For
Bridge Builder Trust54,2345,764 00For
Charles Schwab56,7270 00For
Dimensional49,2180 00For
UNIFIED SERIES TRUST38,3640 00For
Russell Investments33,4750 00For
WisdomTree17,8540 00For
Goldman Sachs17,1480 00For
DIAMOND HILL FUNDS14,8250 00For
American Century013,395 00Against
Transamerica11,2990 00For
Equitable11,1390 00For
Jackson National11,0620 00For
TIAA9,9580 00For
QUANTITATIVE MASTER SERIES LLC8,8980 00For
Invesco8,1860 00For
Lincoln Financial7,8440 00For

Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.

11. Amend Omnibus Stock Plan

COMPENSATION

94% fund support · no official result

FOR 94%

The 2 asset managers below cast 94% of the shares they voted on this item FOR (4,422 for, 300 against).

FOR: 4,422 (93.6%)AGAINST: 300 (6.4%)
Largest asset managers voting on “Amend Omnibus Stock Plan” at Mesa Laboratories, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Empower4,4220 00For
CLEARWATER INVESTMENT TRUST0300 00Against

Largest Mesa Laboratories, Inc. shareholders voting in 2025-2026

Ranked by the number of Mesa Laboratories, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 5,409,155 shares outstanding at the time of that meeting.

Top Mesa Laboratories, Inc. shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1BlackRock 13.57%
2CONESTOGA FUNDS 7.48%
3Vanguard 7.03%
4Royce 4.58%
5Janus Henderson 4.10%
6Ranger Investment Management, L.P. 3.46%
7State Street 3.36%
8GENEVA CAPITAL MANAGEMENT LLC 3.15%
9Conestoga Capital Advisors, LLC 2.54%
10GEODE CAPITAL MANAGEMENT, LLC 2.38%

Reported Mesa Laboratories, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Mesa Laboratories, Inc. beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
Long Path Smaller Companies Fund, LP 7.50% DEF14A
BlackRock 7.28% 13F
Vanguard Group 5.95% 13F
Morgan Stanley 3.25% 13F
AQR Capital 3.15% 13F
Geode Capital 2.37% 13F
Dimensional Fund Advisors 2.30% 13F
State Street 2.26% 13F
Goldman Sachs 1.31% 13F
John Sullivan 1.30% DEF14A

Percentages above are of 5,409,155 shares outstanding, as reported by Mesa Laboratories, Inc. on its Form 10-Q dated 2024-06-30 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Mesa Laboratories, Inc.’s 10-Q dated 2024-06-30. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Mesa Laboratories, Inc.'s shareholder meeting held 2025-08-22, in the 2025-2026 proxy season, 235 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,319 separate fund positions. Their filings are grouped here into 11 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the Company's named executive officer compensation. — FOR was 94% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Mesa Laboratories, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-08-25.

Mesa Laboratories, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).